Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07316491 · ClinicalTrials.gov registry record · NA
Autologous Fat Grafting Beneath Penile Split Thickness Skin Graft Placement During Penile Reconstruction
A NA study, sponsored by University of Pittsburgh.
- Not yet
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT07316491 is a NA study that has not yet begun recruiting, run by University of Pittsburgh. The registered enrollment target is 24 participants.
The verdict
NCT07316491, a NA study, has not yet begun recruiting, sponsored by University of Pittsburgh.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of this randomized interventional clinical trial is to learn if placement of a thin layer of fatty tissue (fat graft) beneath a split-thickness skin graft on the surface of the penis improved outcomes of surgery in men who are scheduled to undergo reconstructive surgery on their penis and genitals. This is a randomized study, meaning that half of participants will receive the fat graft with their standard-of-care surgery, and half will have their standard-of-care surgery alone. Fat grafting underneath split-thickness skin grafts in other parts of the body has been shown to improve healing of the skin graft. Both study groups will be followed for specific outcomes through outpatient clinic visits for the first 12 months after their surgery, as well as chart review. Questions the investigators hope to answer include: * Does fat grafting improve the pliability and feel of the penile skin after grafting * Does fat grafting change the penile length after surgery * Does fat grafting improve sexual function, urinary function, and genital self-image after surgery * Are there any unforeseen complications related to the fat grafting procedure Participants will be asked to complete questionnaires related to sexual, urinary, and genital self-image questionnaires before surgery, 3 months after surgery, and 12 months after surgery. Noninvasive testing of the penile skin will also be performed at participants' routine appointments.
Interventions
- PROCEDURE Autologous fat grafting
- PROCEDURE Genitourinary Reconstruction with Split-Thickness Skin Grafting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07316491
The ClinicalTrials.gov registry entry for NCT07316491 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Autologous fat grafting is the first listed.
NCT07316491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07316491 about?
NCT07316491 is a clinical study titled "Autologous Fat Grafting Beneath Penile Split Thickness Skin Graft Placement During Penile Reconstruction". The goal of this randomized interventional clinical trial is to learn if placement of a thin layer of fatty tissue (fat graft) beneath a split-thickness skin graft on the surface of the penis improved outcomes of surgery in men who are scheduled to undergo reconstructive surgery on their penis and g...
What is the current status of trial NCT07316491?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-06-01. Estimated completion is 2028-03-01.
What interventions are being tested in trial NCT07316491?
The interventions under investigation include: Autologous fat grafting (PROCEDURE), Genitourinary Reconstruction with Split-Thickness Skin Grafting (PROCEDURE).
Who is sponsoring clinical trial NCT07316491?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.